V10N3 June 2019


Once I get on a puzzle, I can't get off: Cachexia and wasting in 2018

Stephan von Haehling, Stefan D. Anker

Cachexia and wasting disorders can still be considered a niche in the medical arena. The Cachexia Conference, held this year in Maastricht, the Netherlands, from December 7 to 9, has helped establishing this field in clinical and basic research. The conference was founded in 2000 with some 100 attendees in Berlin, Germany. The second conference took place in Berlin again with the number of participants already doubled. Later venues included Rome, Italy, in 2005 and Tampa, Florida, in 2007. The initial Cachexia Conferences were held every other year with the number of attendees increasing to some 426 in Paris, France, in 2015. Of course, the location of the conference does play a major role in the decision to participate or not, and therefore, it is not a surprise that the Kobe Conference in 2013 had a slightly lower number of participants than previous ones. The increasing interest in the field of wasting, however, is also highlighted by the increasing number of abstracts presented at the Cachexia Conference from 197 at the meeting in Milan in 2011 to 250 at the meeting in Rome last year. Of note, these abstracts presented in Rome came from no less than 37 different countries around the globe.


Miguel A. Perez-Sousa, Luis Carlos Venegas-Sanabria, Diego Andrés Chavarro-Carvajal, Carlos Alberto Cano-Gutierrez, Mikel Izquierdo, Jorge Enrique Correa-Bautista, Robinson Ramírez-Vélez

Gait speed as a mediator of the effect of sarcopenia on dependency in activities of daily living


Patrick J. Owen, Robin M. Daly, Jack Dalla Via, Niamh L. Mundell, Patricia M. Livingston, Timo Rantalainen, Steve F. Fraser

The clinical relevance of adiposity when assessing muscle health in men treated with androgen deprivation for prostate cancer


Arthur Goron, Frédéric Lamarche, Sandrine Blanchet, Pascale Delangle, Uwe Schlattner, Eric Fontaine, Christophe Moinard

Citrulline stimulates muscle protein synthesis, by reallocating ATP consumption to muscle protein synthesis


Pradeep Harish, Alberto Malerba, Ngoc Lu-Nguyen, Leysa Forrest, Ornella Cappellari, Fanny Roth, Capucine Trollet, Linda Popplewell, George Dickson

Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD)


Douglas W. Gould, Emma L. Watson, Thomas J. Wilkinson, Joanne Wormleighton, Soteris Xenophontos, Joao L. Viana

Ultrasound assessment of muscle mass in response to exercise training in chronic kidney disease: a comparison with MRI





Upcoming Events

Dates: 6-8 December 2019 in Berlin
Berlin - Germany


Editorial Board

Stefan D. Anker, MD, PhD
Goettingen, Germany

Stephan von Haehling, MD, PhD
Goettingen, Germany

Andrew Coats, MB, BChir, MA, DM, DSc., MBA
Australia, UK